Company intelligence / Profile preview
Rakovina Therapeutics
Vancouver, British Columbia, Canadarakovinatherapeutics.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Rakovina Therapeutics has presented promising preclinical data for its lead programs targeting PARP1 and ATR using proprietary AI-driven platforms. Their PARP1-selective inhibitors show improved metabolic stability and CNS penetration potential. The ATR inhibitor program is also progressing rapidly, with potent candidates identified for further validation. No clinical trial results are available yet; the company aims to advance one or more candidates into human trials soon.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculesAI-discovered drug candidates
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Collaboration with Dr. Artem Cherkasov/University of British Columbia for Deep Docking™ platform accessPartnership with Variational AI using their Enki™ platform for novel kinase inhibitor discovery
Beyond the preview
Go deeper on Rakovina Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rakovina Therapeutics.